Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) saw unusually-high trading volume on Wednesday . Approximately 4,191,492 shares changed hands during trading, an increase of 38% from the previous session’s volume of 3,045,478 shares.The stock last traded at $14.08 and had previously closed at $14.12.

MDRX has been the topic of a number of recent research reports. Zacks Investment Research lowered shares of Allscripts Healthcare Solutions from a “buy” rating to a “sell” rating in a research note on Wednesday, April 20th. Jefferies Group restated a “buy” rating and set a $16.50 target price on shares of Allscripts Healthcare Solutions in a research note on Sunday, March 27th. Morgan Stanley upgraded shares of Allscripts Healthcare Solutions from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $15.00 to $16.00 in a research note on Wednesday, March 30th. Canaccord Genuity restated a “buy” rating and set a $18.00 target price on shares of Allscripts Healthcare Solutions in a research note on Thursday, March 24th. Finally, FBR & Co restated a “market perform” rating on shares of Allscripts Healthcare Solutions in a research note on Wednesday, March 23rd. Eleven investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $15.86.

The company has a 50 day moving average of $13.06 and a 200-day moving average of $13.28. The company has a market capitalization of $2.62 billion and a price-to-earnings ratio of 264.72.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last posted its quarterly earnings data on Thursday, May 5th. The company reported $0.13 EPS for the quarter, topping the Zacks’ consensus estimate of $0.12 by $0.01. The firm earned $346 million during the quarter, compared to the consensus estimate of $348.51 million. The firm’s quarterly revenue was up 3.3% on a year-over-year basis. During the same period in the prior year, the firm posted $0.08 EPS. On average, equities analysts forecast that Allscripts Healthcare Solutions Inc. will post $0.58 EPS for the current fiscal year.

In other news, CEO Paul Black sold 15,000 shares of the business’s stock in a transaction on Monday, June 13th. The stock was sold at an average price of $13.04, for a total transaction of $195,600.00. Following the sale, the chief executive officer now directly owns 1,197,329 shares of the company’s stock, valued at $15,613,170.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, President Richard J. Poulton sold 10,000 shares of the business’s stock in a transaction on Monday, June 13th. The stock was sold at an average price of $13.03, for a total value of $130,300.00. Following the sale, the president now directly owns 343,813 shares in the company, valued at $4,479,883.39. The disclosure for this sale can be found here.

Other large investors recently made changes to their positions in the company. Tamarack Advisers LP bought a new stake in shares of Allscripts Healthcare Solutions during the fourth quarter worth about $28,453,000. Cornerstone Capital Management Holdings LLC. raised its stake in shares of Allscripts Healthcare Solutions by 24.1% in the fourth quarter. Cornerstone Capital Management Holdings LLC. now owns 994,225 shares of the company’s stock worth $15,291,000 after buying an additional 193,111 shares during the period. Principal Financial Group Inc. raised its stake in shares of Allscripts Healthcare Solutions by 2.5% in the fourth quarter. Principal Financial Group Inc. now owns 608,152 shares of the company’s stock worth $9,353,000 after buying an additional 14,595 shares during the period. Russell Frank Co raised its stake in shares of Allscripts Healthcare Solutions by 48.4% in the fourth quarter. Russell Frank Co now owns 603,169 shares of the company’s stock worth $9,300,000 after buying an additional 196,775 shares during the period. Finally, California Public Employees Retirement System raised its stake in shares of Allscripts Healthcare Solutions by 6.3% in the fourth quarter. California Public Employees Retirement System now owns 560,700 shares of the company’s stock worth $8,624,000 after buying an additional 33,200 shares during the period.

Allscripts Healthcare Solutions, Inc delivers information technology (IT) and services to help healthcare organizations in clinical, financial and operational results. The Company operates through two segments: Clinical and Financial Solutions, and Population Health. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions, which primarily include electronic health record (EHR)-related software, financial and practice management software, related installation, support and maintenance, outsourcing, hosting, revenue cycle management, training and electronic claims administration services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.